NEW YORK (GenomeWeb News) – Laboratory Corporation of America is offering Roche's new Cobas AmpliPrep/Cobas TaqMan HCV test, which the US Food and Drug Administration cleared for marketing in October 2008.

The test is fully automated and uses Roche's proprietary real-time PCR technology to quantify the amount of virus in an individual's blood. Physicians can use it to monitor viral load at baseline and during treatment to help determine the effectiveness of therapy.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

National Institutes of Health Director Francis Collins appears before a House subcommittee to discuss his agency's budget request.

In PNAS this week: Akt3 amplification in glioma progression, Tibetan Plateau frog genome, and more.

The US Supreme Court has declined to review a decision involving the use of "inadvertently shed" DNA in a police investigation and subsequent conviction.

A panel at the New York Times discusses anonymity and privacy of users of 23andMe's services when access to its database is offered for research.